Gene · 573
Papers2,074
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,074
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design strategies for composite matrix and multifunctional polymeric scaffolds with enhanced bioactivity for bone tissue engineering. | Front Chem | 2022 | 36518978 | PubTator, text mining | PubMed |
| Enhancement of photocatalytic efficacy by exploiting copper doping in nano-hydroxyapatite for degradation of Congo red dye. | RSC Adv | 2022 | 36505682 | PubTator, text mining | PubMed |
| Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance. | Cancers (Basel) | 2022 | 36497277 | PubTator, text mining | PubMed |
| Preparation and application of calcium phosphate nanocarriers in drug delivery. | Mater Today Bio | 2022 | 36466957 | PubTator, text mining | PubMed |
| Morphology, oxygen vacancies, and other factors affecting the performance of supported bimetallic ceria catalysts. | iScience | 2022 | 36465099 | PubTator, text mining | PubMed |
| Role of androgen receptor signaling pathway-related lncRNAs in the prognosis and immune infiltration of breast cancer. | Sci Rep | 2022 | 36450882 | PubTator, text mining | PubMed |
| Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor-Positive, ERBB2-Negative Breast Cancer. | JAMA Netw Open | 2022 | 36441548 | PubTator, text mining | PubMed |
| The determinants regulating Toxoplasma gondii bradyzoite development. | Front Microbiol | 2022 | 36439853 | PubTator, text mining | PubMed |
| Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management. | J Transl Med | 2022 | 36435779 | PubTator, text mining | PubMed |
| Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review. | Int J Mol Sci | 2022 | 36430164 | PubTator, text mining | PubMed |
| Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | 36428760 | PubTator, text mining | PubMed |
| Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment. | J Biol Chem | 2022 | 36395883 | PubTator, text mining | PubMed |
| microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection. | Front Cell Infect Microbiol | 2022 | 36389170 | PubTator, text mining | PubMed |
| Whole exome sequencing identified a novel POT1 variant as a candidate pathogenic allele underlying a Li-Fraumeni-like family. | Front Oncol | 2022 | 36387164 | PubTator, text mining | PubMed |
| Role of microRNAs and long non‑coding RNAs in glucocorticoid signaling (Review). | Int J Mol Med | 2022 | 36367164 | PubTator, text mining | PubMed |
| Zinc Finger Proteins: Functions and Mechanisms in Colon Cancer. | Cancers (Basel) | 2022 | 36358661 | PubTator, text mining | PubMed |
| Human MHC class I molecule, HLA-A2.1, mediates activation of CD8+ T cell IFN-γ production and the T cell-dependent protection against reactivation of cerebral Toxoplasma infection. | Front Immunol | 2022 | 36311799 | PubTator, text mining | PubMed |
| Intelligent Traffic Monitoring through Heterogeneous and Autonomous Networks Dedicated to Traffic Automation. | Sensors (Basel) | 2022 | 36298212 | PubTator, text mining | PubMed |
| Evaluation of Human Osteoblasts on NIPS Micro-Patterned PCL Carriers Containing Nanohydroxyapatite and Reduced Graphene Oxide Using PSµM. | Molecules | 2022 | 36296680 | PubTator, text mining | PubMed |
| Biological and Physico-Chemical Properties of Composite Layers Based on Magnesium-Doped Hydroxyapatite in Chitosan Matrix. | Micromachines (Basel) | 2022 | 36295927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/573/papers?page=12